Study of Home Monitoring system Safety and Efficacy in Cardiac Implantable Electronic Device (CIED) implanted patients (SUMMIT) – ICD and CRTD

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONRC-13003694

Enrollment

Unknown

Registered

2013-10-11

Start date

2013-10-08

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular Tachycardia?Ventricular Fibrillation

Interventions

experimental group:ICD

control group:ICD

Eligibility

Sex/Gender

All

Age

18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Meet the indications of ICD, CRTD implantation, not limited to primary or secondary prevention; 2. Implanted BIOTRONIK ICD or CRTD with immediate successful implantation; 3. Patient has provided informed consent; 4. Able to complete the follow-up according to protocol.

Exclusion criteria

Exclusion criteria: 1. Life expectancy of <2 years; 2. Participated in other clinical trials which may influence the outcome of this study.

Design outcomes

Primary

Measure	Time frame
Proportion of patients experiencing VF episodes;Proportion of patients experiencing VT episodes;Proportion of patients experiencing ICD shock;	—

Secondary

Measure	Time frame
Numbers of ATP therapy;Numbers of successful ATP therapy;Changes in cardiac function (NYHA BNP Echo:LVEDD, LVEF, BNP);SSAE (Death cardiovascular hospitalization);	—

Countries

China

Contacts

Public ContactWang Jing

jing.wang@biotronik.com+86 010-65223851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026